Publicaciones en las que colabora con LAURA LUISA PEÑA FERNÁNDEZ (46)

2023

  1. Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients

    Cells, Vol. 12, Núm. 18

  2. Transcriptomics of Canine Inflammatory Mammary Cancer Treated with Empty Cowpea Mosaic Virus Implicates Neutrophils in Anti-Tumor Immunity

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer

    Research in Veterinary Science, Vol. 152, pp. 307-313

  2. Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase-2 inhibitor and toceranib phosphate

    Veterinary and Comparative Oncology, Vol. 20, Núm. 1, pp. 179-188

  3. Epitheliosis is a histopathological finding associated with malignancy and poor prognosis in dogs with mammary tumors

    Veterinary Pathology, Vol. 59, Núm. 5, pp. 747-758

  4. Hormonal Homologies between Canine Mammary Cancer and Human Breast Cancer in a Series of Cases

    Veterinary Sciences, Vol. 9, Núm. 8

  5. Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer

    Journal for immunotherapy of cancer, Vol. 10, Núm. 3

2020

  1. Investigación original sobre la epiteliosis mamaria canina. Una amenaza de interés en la clínica oncológica de pequeños animales

    Anales de la Real Academia de Ciencias Veterinarias, Vol. 28, Núm. 28, pp. 13-42

  2. Tumores mamarios en perras y gatas

    Profesión veterinaria, Vol. 23, Núm. 94, pp. 46-58

2019

  1. P-Glycoprotein and Breast Cancer Resistance Protein in Canine Inflammatory and Noninflammatory Grade III Mammary Carcinomas

    Veterinary Pathology, Vol. 56, Núm. 6, pp. 840-847

2017

  1. Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications

    Veterinary and Comparative Oncology, Vol. 15, Núm. 2, pp. 383-390

2016

  1. Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: A case-control prospective study

    Veterinary Record, Vol. 179, Núm. 5, pp. 125

  2. Profile of Steroid Receptors and Increased Aromatase Immunoexpression in Canine Inflammatory Mammary Cancer as a Potential Therapeutic Target

    Reproduction in Domestic Animals, Vol. 51, Núm. 2, pp. 269-275

2014

  1. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours

    Veterinary Record, Vol. 175, Núm. 16, pp. 403

2013

  1. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer

    Veterinary Immunology and Immunopathology, Vol. 152, Núm. 3-4, pp. 245-251

  2. Prognostic Value of Histological Grading in Noninflammatory Canine Mammary Carcinomas in a Prospective Study With Two-Year Follow-Up: Relationship With Clinical and Histological Characteristics

    Veterinary Pathology, Vol. 50, Núm. 1, pp. 94-105

2011

  1. Actualización en el diagnóstico y tratamiento de los tumores mamarios caninos

    Argos: Informativo Veterinario, Núm. 132, pp. 56-63

  2. Actualización en el diagnóstico y tratamiento de los tumores mamarios felinos

    Argos: Informativo Veterinario, Núm. 132, pp. 64-66

2010

  1. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer

    Veterinary Pathology, Vol. 47, Núm. 2, pp. 265-274

  2. Metastasis of canine inflammatory versus non-inflammatory mammary tumours

    Journal of Comparative Pathology, Vol. 143, Núm. 2-3, pp. 157-163